All

Top 10 global pharmaceutical companies by 2025 (based on each company's 2024 revenue data).

In 2024, recombinant collagen, as an emerging force in the cosmetics industry, is experiencing a golden growth period.

The pilot platform for biological reactions is a key link connecting laboratory trials with industrial production, and its construction requires comprehensive consideration of various factors such as technology, engineering, regulations, and safety.

Driven by national policies, synthetic biology is becoming a rapidly developing emerging industry in various regions.

Fermented products achieve large-scale production from basic nutrients (probiotics, collagen) to high-end drugs (insulin, semaglutide) through the metabolic activities of microorganisms (bacteria, fungi, engineered bacteria).

Synthetic biology provides great prospects for scientists to solve important social problems.

Astaxanthin is a multifunctional natural compound widely used in the fields of food, medicine, and skincare.

Intelligent fermentation factory design: large-scale IoT perception, multi-source big data analysis

The core logic of these directions is to achieve global optimization of the fermentation process from cell growth to product synthesis through closed-loop control driven by metabolic demands, stage adapted resource allocation, and multidimensional interference suppression.

The difference in yield between fermenter fermentation and shake flask fermentation is influenced by various factors, and the magnitude of the difference varies depending on the specific situation.

Efficient fermentation technology is an important field in modern biotechnology and industrial production, with the goal of improving the yield, efficiency, and stability of the fermentation process. Bailun has summarized 10 efficient fermentation techniques.

As the core equipment of modern biomanufacturing, bioreactors support the production of key products in various fields from medicine to industry, food, and more.

From Novo Nordisk breaking the monopoly of peptide drugs with gene edited E. coli, to Ginkgo Bioworks rewriting the logic of chemical production with AI designed "super strains".

The United States is at the forefront of synthetic biology.